Mauritius
Diabetes country report 2000 — 2050
Number of adults (20–79 years) with diabetes in Mauritius (MU)
2000 | 112.6 thousand |
2011 | 138.2 thousand |
2024 | 218.1 thousand |
2050 | 247.5 thousand |
Mauritius is one of the seven countries and territories in the IDF South-East Asia Region. Mauritius has the highest diabetes prevalence (20-79 years) in the Region.
Data source(s) used for the diabetes estimates in adults:
- Ministry of Health and Wellness, Republic of Mauritius, National Health Survey, 2021.
Diabetes estimates (20-79 y) | ||||
---|---|---|---|---|
People with diabetes, in 1,000s | 112.6 | 138.2 | 218.1 | 247.5 |
Age-standardised prevalence of diabetes, % | 15.0 | 14.8 | 20.1 | 23.5 |
Proportion of people with undiagnosed diabetes, % | - | - | 28.2 | - |
People with undiagnosed diabetes, in 1,000s | - | - | 61.4 | - |
Impaired Fasting Glucose (IFG) | ||||
---|---|---|---|---|
People with IFG, in 1,000s | - | - | 59.4 | 63.7 |
Age-standardised prevalence of IFG, % | - | - | 5.7 | 6.4 |
Impaired Glucose Tolerance (IGT) | ||||
---|---|---|---|---|
People with IGT, in 1,000s | - | 95.3 | 118.3 | 115.1 |
Age-standardised prevalence of IGT, % | - | 10.3 | 11.8 | 12.3 |
Mortality attributable to diabetes (20-79 y) | ||||
---|---|---|---|---|
Deaths attributable to diabetes | - | 1,609.0 | 814.7 | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 10.0 | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
---|---|---|---|---|
Live births affected by HIP | - | - | - | - |
Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - |
Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - |
Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - |
Diabetes-related health expenditure | ||||
---|---|---|---|---|
Total diabetes-related health expenditure, USD million | - | - | 146.4 | 156.8 |
Total diabetes-related health expenditure, ID million | - | - | 309.5 | 331.4 |
Diabetes-related health expenditure per person, USD | - | 478.0 | 671.3 | 633.6 |
Diabetes-related health expenditure per person, ID | - | - | 1,418.7 | 1,339.0 |
Type 1 diabetes estimates in children and adolescents | ||||
---|---|---|---|---|
People with type 1 diabetes (all age groups) | - | - | 4,170.0 | - |
People with type 1 diabetes (0-19 y) | - | - | 363.6 | - |
Demographics | ||||
---|---|---|---|---|
Total adult population (20-79 y), in 1,000s | 753.0 | 898.9 | 981.0 | 912.7 |
Population of children and adolescents (0-19 y) | - | - | 273,735.0 | - |
Diabetes estimates (20-79 y) | |
---|---|
People with diabetes, in 1,000s | 112.6 |
Age-standardised prevalence of diabetes, % | 15.0 |
Proportion of people with undiagnosed diabetes, % | - |
People with undiagnosed diabetes, in 1,000s | - |
Impaired Fasting Glucose (IFG) | |
---|---|
People with IFG, in 1,000s | - |
Age-standardised prevalence of IFG, % | - |
Impaired Glucose Tolerance (IGT) | |
---|---|
People with IGT, in 1,000s | - |
Age-standardised prevalence of IGT, % | - |
Mortality attributable to diabetes (20-79 y) | |
---|---|
Deaths attributable to diabetes | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
---|---|
Live births affected by HIP | - |
Prevalence of gestational diabetes mellitus (GDM), % | - |
Live births affected by other types of diabetes first detected in pregnancy | - |
Live births affected by other types of diabetes detected prior to pregnancy | - |
Diabetes-related health expenditure | |
---|---|
Total diabetes-related health expenditure, USD million | - |
Total diabetes-related health expenditure, ID million | - |
Diabetes-related health expenditure per person, USD | - |
Diabetes-related health expenditure per person, ID | - |
Type 1 diabetes estimates in children and adolescents | |
---|---|
People with type 1 diabetes (all age groups) | - |
People with type 1 diabetes (0-19 y) | - |
Demographics | |
---|---|
Total adult population (20-79 y), in 1,000s | 753.0 |
Population of children and adolescents (0-19 y) | - |